168 related articles for article (PubMed ID: 1866388)
1. Improvement of glucose homeostasis by oral vanadyl or vanadate treatment in diabetic rats is accompanied by negative side effects.
Domingo JL; Gómez M; Llobet JM; Corbella J; Keen CL
Pharmacol Toxicol; 1991 Apr; 68(4):249-53. PubMed ID: 1866388
[TBL] [Abstract][Full Text] [Related]
2. Oral vanadate and Tiron in treatment of diabetes mellitus in rats: improvement of glucose homeostasis and negative side-effects.
Domingo JL; Sanchez DJ; Gomez M; Llobet JM; Corbella J
Vet Hum Toxicol; 1993 Dec; 35(6):495-500. PubMed ID: 8303815
[TBL] [Abstract][Full Text] [Related]
3. Oral vanadium administration to streptozotocin-diabetic rats has marked negative side-effects which are independent of the form of vanadium used.
Domingo JL; Gomez M; Llobet JM; Corbella J; Keen CL
Toxicology; 1991 Mar; 66(3):279-87. PubMed ID: 1826377
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like effect of vanadyl ion on streptozotocin-induced diabetic rats.
Sakurai H; Tsuchiya K; Nukatsuka M; Sofue M; Kawada J
J Endocrinol; 1990 Sep; 126(3):451-9. PubMed ID: 2170556
[TBL] [Abstract][Full Text] [Related]
5. Long-term effectiveness of oral vanadyl sulphate in streptozotocin-diabetic rats.
Cam MC; Pederson RA; Brownsey RW; McNeill JH
Diabetologia; 1993 Mar; 36(3):218-24. PubMed ID: 8462769
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of various vanadium salts on glucose homeostasis in streptozotocin-diabetic rats.
Becker DJ; Ongemba LN; Henquin JC
Eur J Pharmacol; 1994 Aug; 260(2-3):169-75. PubMed ID: 7988641
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of some chelating agents on distribution and excretion of vanadium in rats after prolonged oral administration.
Gómez M; Domingo JL; Llobet JM; Corbella J
J Appl Toxicol; 1991 Jun; 11(3):195-98. PubMed ID: 1918793
[TBL] [Abstract][Full Text] [Related]
8. Administration of vanadyl sulfate by gavage does not normalize blood glucose levels in streptozotocin-induced diabetic rats.
Domingo JL; Sanchez DJ; Gomez M; Llobet JM; Corbella J
Res Commun Chem Pathol Pharmacol; 1992 Mar; 75(3):369-72. PubMed ID: 1509205
[TBL] [Abstract][Full Text] [Related]
9. Toxicological aspects of vanadyl sulphate on diabetic rats: effects on vanadium levels and pancreatic B-cell morphology.
Mongold JJ; Cros GH; Vian L; Tep A; Ramanadham S; Siou G; Diaz J; McNeill JH; Serrano JJ
Pharmacol Toxicol; 1990 Sep; 67(3):192-8. PubMed ID: 2255674
[TBL] [Abstract][Full Text] [Related]
10. One-year treatment of streptozotocin-induced diabetic rats with vanadyl sulphate.
Dai S; Thompson KH; McNeill JH
Pharmacol Toxicol; 1994 Feb; 74(2):101-9. PubMed ID: 8190697
[TBL] [Abstract][Full Text] [Related]
11. Long-term effects of vanadyl treatment on streptozocin-induced diabetes in rats.
Pederson RA; Ramanadham S; Buchan AM; McNeill JH
Diabetes; 1989 Nov; 38(11):1390-5. PubMed ID: 2695373
[TBL] [Abstract][Full Text] [Related]
12. Long term improvement of glucose homeostasis by vanadate treatment in diabetic rats.
Brichard SM; Okitolonda W; Henquin JC
Endocrinology; 1988 Oct; 123(4):2048-53. PubMed ID: 3046930
[TBL] [Abstract][Full Text] [Related]
13. Enhanced in vivo sensitivity of vanadyl-treated diabetic rats to insulin.
Ramanadham S; Cros GH; Mongold JJ; Serrano JJ; McNeill JH
Can J Physiol Pharmacol; 1990 Apr; 68(4):486-91. PubMed ID: 2183918
[TBL] [Abstract][Full Text] [Related]
14. Oral vanadyl sulfate in treatment of diabetes mellitus in rats.
Ramanadham S; Mongold JJ; Brownsey RW; Cros GH; McNeill JH
Am J Physiol; 1989 Sep; 257(3 Pt 2):H904-11. PubMed ID: 2675634
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the glucose-lowering properties of vanadyl sulfate and bis(maltolato)oxovanadium(IV) following acute and chronic administration.
Yuen VG; Orvig C; McNeill JH
Can J Physiol Pharmacol; 1995 Jan; 73(1):55-64. PubMed ID: 7600453
[TBL] [Abstract][Full Text] [Related]
16. Tiron administration minimizes the toxicity of vanadate but not its insulin mimetic properties in diabetic rats.
Domingo JL; Gomez M; Sanchez DJ; Llobet JM; Keen CL
Life Sci; 1992; 50(18):1311-7. PubMed ID: 1532846
[TBL] [Abstract][Full Text] [Related]
17. Effects of vanadium complexes with organic ligands on glucose metabolism: a comparison study in diabetic rats.
Reul BA; Amin SS; Buchet JP; Ongemba LN; Crans DC; Brichard SM
Br J Pharmacol; 1999 Jan; 126(2):467-77. PubMed ID: 10077240
[TBL] [Abstract][Full Text] [Related]
18. Effect of Vanadyl Rosiglitazone, a New Insulin-Mimetic Vanadium Complexes, on Glucose Homeostasis of Diabetic Mice.
Jiang P; Dong Z; Ma B; Ni Z; Duan H; Li X; Wang B; Ma X; Wei Q; Ji X; Li M
Appl Biochem Biotechnol; 2016 Nov; 180(5):841-851. PubMed ID: 27240663
[TBL] [Abstract][Full Text] [Related]
19. Oral administration of vanadate normalizes blood glucose levels in streptozotocin-treated rats. Characterization and mode of action.
Meyerovitch J; Farfel Z; Sack J; Shechter Y
J Biol Chem; 1987 May; 262(14):6658-62. PubMed ID: 2952656
[TBL] [Abstract][Full Text] [Related]
20. The effect of vanadyl treatment on vascular responsiveness of streptozotocin-diabetic rats.
Ozçelikay AT; Pekiner C; Ari N; Oztürk Y; Ozüari A; Altan VM
Diabetologia; 1994 Jun; 37(6):572-8. PubMed ID: 7926341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]